688639 华恒生物
已收盘 12-16 15:00:00
资讯
新帖
简况
华恒生物（688639）披露向控股子公司提供不超过4亿元财务资助，12月16日股价下跌1.62%
证券之星 · 12-16 22:11
华恒生物（688639）披露向控股子公司提供不超过4亿元财务资助，12月16日股价下跌1.62%
华恒生物（688639）披露召开2025年第四次临时股东会通知，12月9日股价下跌2.22%
证券之星 · 12-09
华恒生物（688639）披露召开2025年第四次临时股东会通知，12月9日股价下跌2.22%
12月5日华恒生物涨6.93%，交银先进制造混合A基金重仓该股
证券之星 · 12-05
12月5日华恒生物涨6.93%，交银先进制造混合A基金重仓该股
华恒生物IPO：净利润连年走低毛利率已腰斩 供需格局反转产能过剩或仍将加剧
新浪证券 · 11-20
华恒生物IPO：净利润连年走低毛利率已腰斩 供需格局反转产能过剩或仍将加剧
新股消息 | 华恒生物(688639.SH)拟港股上市 中国证监会要求补充说明近三年技术出口业务的开展情况等
智通财经网 · 11-14
新股消息 | 华恒生物(688639.SH)拟港股上市 中国证监会要求补充说明近三年技术出口业务的开展情况等
华恒生物（688639）公司公告选举第五届董事会成员，11月12日股价上涨0.34%
证券之星 · 11-12
华恒生物（688639）公司公告选举第五届董事会成员，11月12日股价上涨0.34%
每周股票复盘：华恒生物（688639）将召开股东会选举新一届董事
证券之星 · 11-09
每周股票复盘：华恒生物（688639）将召开股东会选举新一届董事
华恒生物（688639）披露拟选举第五届董事会成员，11月05日股价下跌0.26%
证券之星 · 11-05
华恒生物（688639）披露拟选举第五届董事会成员，11月05日股价下跌0.26%
图解华恒生物三季报：第三季度单季净利润同比增长161.22%
证券之星 · 10-28
图解华恒生物三季报：第三季度单季净利润同比增长161.22%
华恒生物(688639.SH)发行H股备案申请材料获中国证监会接收
智通财经 · 10-20
华恒生物(688639.SH)发行H股备案申请材料获中国证监会接收
新股消息 | 华恒生物递表港交所，L-丙氨酸及L-缬氨酸的市场份额分别位居全球第一
智通财经 · 09-30
新股消息 | 华恒生物递表港交所，L-丙氨酸及L-缬氨酸的市场份额分别位居全球第一
每周股票复盘：华恒生物（688639）拟发行H股赴港上市
证券之星 · 09-21
每周股票复盘：华恒生物（688639）拟发行H股赴港上市
华恒生物（688639）披露核心技术人员离职事项，9月18日股价下跌3.18%
证券之星 · 09-18
华恒生物（688639）披露核心技术人员离职事项，9月18日股价下跌3.18%
华恒生物冲刺“A+H”：上半年净利降超两成，主要产品价格下跌
新京报 · 09-17
华恒生物冲刺“A+H”：上半年净利降超两成，主要产品价格下跌
合成生物龙头A+H上市加速，利润连降能否获得港股青睐？
投资时报 · 09-08
合成生物龙头A+H上市加速，利润连降能否获得港股青睐？
每周股票复盘：华恒生物（688639）拟发行H股募资用于全球化布局
证券之星 · 09-07
每周股票复盘：华恒生物（688639）拟发行H股募资用于全球化布局
华恒生物(688639.SH)拟发行H股股票并在香港联交所主板挂牌上市
智通财经 · 09-04
华恒生物(688639.SH)拟发行H股股票并在香港联交所主板挂牌上市
华恒生物：拟发行H股股票并在香港联交所主板挂牌上市
格隆汇 · 09-04
华恒生物：拟发行H股股票并在香港联交所主板挂牌上市
9月4日华恒生物跌6.07%，交银先进制造混合A基金重仓该股
证券之星 · 09-04
9月4日华恒生物跌6.07%，交银先进制造混合A基金重仓该股
华恒生物(688639.SH)：上半年净利润1.15亿元，同比下降23.26%
格隆汇 · 08-27
华恒生物(688639.SH)：上半年净利润1.15亿元，同比下降23.26%
加载更多
公司概况
公司名称：
安徽华恒生物科技股份有限公司
所属行业：
化学原料和化学制品制造业
上市日期：
2021-04-22
主营业务：
安徽华恒生物科技股份有限公司的主营业务是氨基酸及其衍生物产品研发、生产、销售。公司的主要产品是氨基酸及其衍生物产品。
发行价格：
23.16
{"stockData":{"symbol":"688639","market":"SH","secType":"STK","nameCN":"华恒生物","latestPrice":34.55,"timestamp":1765868400000,"preClose":35.12,"halted":0,"volume":4082542,"delay":0,"changeRate":-0.0162,"floatShares":250000000,"shares":250000000,"eps":0.7487,"marketStatus":"已收盘","change":-0.57,"latestTime":"12-16 15:00:00","open":35.2,"high":35.4,"low":34.2,"amount":142000000,"amplitude":0.0342,"askPrice":34.58,"askSize":27,"bidPrice":34.55,"bidSize":9,"shortable":0,"etf":0,"ttmEps":0.7487,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765935000000},"marketStatusCode":5,"adr":0,"adjPreClose":35.12,"symbolType":"stock_kcb","openAndCloseTimeList":[[1765848600000,1765855800000],[1765861200000,1765868400000]],"highLimit":38.63,"lowLimit":31.61,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":250115693,"isCdr":false,"pbRate":3.22,"roa":"--","peRate":46.146654,"roe":"6.37%","epsLYR":0.82,"committee":-0.255102,"marketValue":8641000000,"turnoverRate":0.0163,"status":1,"afterMarket":{"amount":0,"volume":0,"close":34.55,"buyVolume":0,"sellVolume":0,"time":1765870437768,"indexStatus":"已收盘 12-16 15:30:00","preClose":35.12},"floatMarketCap":8641000000},"requestUrl":"/m/hq/s/688639","defaultTab":"news","newsList":[{"id":"2591980971","title":"华恒生物（688639）披露向控股子公司提供不超过4亿元财务资助，12月16日股价下跌1.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591980971","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591980971?lang=zh_cn&edition=full","pubTime":"2025-12-16 22:11","pubTimestamp":1765894305,"startTime":"0","endTime":"0","summary":"截至2025年12月16日收盘，华恒生物报收于34.55元，较前一交易日下跌1.62%，最新总市值为86.41亿元。赤峰智合为公司间接控股子公司，资信良好，无不良记录。截至2025年11月30日，公司累计提供财务资助余额为12.45亿元，占最近一期经审计净资产的48.65%，无逾期未收回情况。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600040544.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["91286","BK0229","688639"],"gpt_icon":0},{"id":"2590134423","title":"华恒生物（688639）披露召开2025年第四次临时股东会通知，12月9日股价下跌2.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590134423","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590134423?lang=zh_cn&edition=full","pubTime":"2025-12-09 22:11","pubTimestamp":1765289490,"startTime":"0","endTime":"0","summary":"截至2025年12月9日收盘，华恒生物报收于34.37元，较前一交易日下跌2.22%，最新总市值为85.96亿元。该股当日开盘35.07元，最高35.69元，最低34.32元，成交额达1.74亿元，换手率为2.0%。公司近日发布公告称，安徽华恒生物科技股份有限公司将于2025年12月25日召开2025年第四次临时股东会，会议采取现场投票与网络投票相结合的方式。股权登记日为2025年12月18日，A股股东可参会。股东可于2025年12月19日办理登记。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120900040301.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","91286","BK0229"],"gpt_icon":0},{"id":"2589646678","title":"12月5日华恒生物涨6.93%，交银先进制造混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2589646678","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589646678?lang=zh_cn&edition=full","pubTime":"2025-12-05 15:34","pubTimestamp":1764920087,"startTime":"0","endTime":"0","summary":"证券之星消息，12月5日华恒生物涨6.93%，收盘报33.78元，换手率3.57%，成交量8.93万手，成交额2.95亿元。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为交银施罗德基金的交银先进制造混合A。交银先进制造混合A目前规模为44.97亿元，最新净值5.2609，较上一交易日上涨0.19%，近一年上涨43.36%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500017926.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["399260","688639","BK0229","91286"],"gpt_icon":0},{"id":"2584181909","title":"华恒生物IPO：净利润连年走低毛利率已腰斩 供需格局反转产能过剩或仍将加剧","url":"https://stock-news.laohu8.com/highlight/detail?id=2584181909","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584181909?lang=zh_cn&edition=full","pubTime":"2025-11-20 16:59","pubTimestamp":1763629140,"startTime":"0","endTime":"0","summary":" 近日，A股科创板上市公司华恒生物向香港联合交易所递交上市申请，拟实现“A+H”两地上市，华泰国际为其独家保荐人。 公开资料显示，华恒生物专注于依托生物制造技术，开展生物基产品的研发、生产和销售，以2024年收入为衡量标准，公司L-丙氨酸及L-缬氨酸的市场份额分别位居全球第一。然而，在光鲜外表之下，公司正面临着产品价格持续下跌、毛利率大幅下滑、行业竞争加剧等多重风险。华恒生物毛利率在可比企业中排名垫底。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2025-11-20/doc-infxzvky2227303.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688639","91286"],"gpt_icon":0},{"id":"2583503522","title":"新股消息 | 华恒生物(688639.SH)拟港股上市 中国证监会要求补充说明近三年技术出口业务的开展情况等","url":"https://stock-news.laohu8.com/highlight/detail?id=2583503522","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583503522?lang=zh_cn&edition=full","pubTime":"2025-11-14 19:37","pubTimestamp":1763120241,"startTime":"0","endTime":"0","summary":"据港交所9月30日披露，安徽华恒生物科技股份有限公司(简称：华恒生物)向港交所主板提交上市申请书，华泰国际为独家保荐人。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20251114/20251114193747_53907.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20251114/20251114193747_53907.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1369525.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0229","688639","91286"],"gpt_icon":0},{"id":"2582370978","title":"华恒生物（688639）公司公告选举第五届董事会成员，11月12日股价上涨0.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582370978","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582370978?lang=zh_cn&edition=full","pubTime":"2025-11-12 22:48","pubTimestamp":1762958901,"startTime":"0","endTime":"0","summary":"截至2025年11月12日收盘，华恒生物报收于38.53元，较前一交易日上涨0.34%，最新总市值为96.37亿元。该股当日开盘37.98元，最高39.3元，最低36.93元，成交额达4.32亿元，换手率为4.52%。近日，安徽华恒生物科技股份有限公司发布2025年第三次临时股东会决议公告，公司于2025年11月12日召开2025年第三次临时股东会，审议通过了选举第五届董事会非独立董事和独立董事的议案。会议表决程序合法，决议有效。出席会议股东所持表决权占公司有效表决权总数的37.08%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200041694.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229","91286"],"gpt_icon":0},{"id":"2582687861","title":"每周股票复盘：华恒生物（688639）将召开股东会选举新一届董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2582687861","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582687861?lang=zh_cn&edition=full","pubTime":"2025-11-09 03:46","pubTimestamp":1762631179,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，华恒生物报收于36.29元，较上周的35.85元上涨1.23%。本周关注点公司公告汇总：华恒生物将于2025年11月12日召开第三次临时股东会，审议选举第五届董事会非独立董事和独立董事事项。公司公告汇总安徽华恒生物科技股份有限公司将于2025年11月12日召开2025年第三次临时股东会，会议采用现场与网络投票相结合方式。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900001352.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["91286","688639","BK0229"],"gpt_icon":0},{"id":"2581206775","title":"华恒生物（688639）披露拟选举第五届董事会成员，11月05日股价下跌0.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581206775","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581206775?lang=zh_cn&edition=full","pubTime":"2025-11-05 22:22","pubTimestamp":1762352539,"startTime":"0","endTime":"0","summary":"截至2025年11月5日收盘，华恒生物报收于34.66元，较前一交易日下跌0.26%，最新总市值为86.69亿元。该股当日开盘34.33元，最高35.85元，最低34.33元，成交额达2.21亿元，换手率为2.52%。根据公司近日发布的公告，安徽华恒生物科技股份有限公司将于2025年11月12日召开2025年第三次临时股东会，会议将审议选举公司第五届董事会非独立董事和独立董事的相关议案。上述候选人任期三年，自股东会审议通过之日起就任。会议将采用累积投票制进行表决。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500040698.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["91286","688639","BK0229"],"gpt_icon":0},{"id":"2578279826","title":"图解华恒生物三季报：第三季度单季净利润同比增长161.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578279826","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578279826?lang=zh_cn&edition=full","pubTime":"2025-10-28 03:00","pubTimestamp":1761591650,"startTime":"0","endTime":"0","summary":"证券之星消息，华恒生物2025年三季报显示，公司主营收入21.94亿元，同比上升42.53%；归母净利润1.68亿元，同比下降1.34%；扣非净利润1.67亿元，同比上升0.8%；其中2025年第三季度，公司单季度主营收入7.04亿元，同比上升34.73%；单季度归母净利润5272.94万元，同比上升161.22%；单季度扣非净利润5220.68万元，同比上升187.98%；负债率52.96%，投资收益-161.75万元，财务费用2844.11万元，毛利率23.55%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800002349.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["91286","688639"],"gpt_icon":0},{"id":"2576313558","title":"华恒生物(688639.SH)发行H股备案申请材料获中国证监会接收","url":"https://stock-news.laohu8.com/highlight/detail?id=2576313558","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576313558?lang=zh_cn&edition=full","pubTime":"2025-10-20 16:37","pubTimestamp":1760949478,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华恒生物(688639.SH)发布公告，公司已于2025年9月30日向香港联合交易所有限公司(简称“香港联交所”)递交了发行H股股票并在香港联交所主板挂牌上市的申请，并于同日在香港联交所网站刊登了本次发行上市的申请资料。公司根据相关规定已向中国证券监督管理委员会(简称“中国证监会”)报送了本次发行上市的备案申请材料，并于近日获中国证监会接收。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1357054.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688639","91286","BK0229"],"gpt_icon":0},{"id":"2571399821","title":"新股消息 | 华恒生物递表港交所，L-丙氨酸及L-缬氨酸的市场份额分别位居全球第一","url":"https://stock-news.laohu8.com/highlight/detail?id=2571399821","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571399821?lang=zh_cn&edition=full","pubTime":"2025-09-30 10:41","pubTimestamp":1759200063,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据港交所9月30日披露，安徽华恒生物科技股份有限公司向港交所主板提交上市申请书，华泰国际为独家保荐人。根据弗若斯特沙利文的资料：该公司是全球通过合成生物技术实现商业化应用产品最全面生物基产品的企业之一;该公司是全球首家实现系列氨基酸厌氧发酵法产业化的企业;及以2024年收入为衡量标准，该公司L-丙氨酸及L-缬氨酸的市场份额分别位居全球第一。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1351078.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688639","BK0229","91286"],"gpt_icon":0},{"id":"2569246656","title":"每周股票复盘：华恒生物（688639）拟发行H股赴港上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2569246656","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569246656?lang=zh_cn&edition=full","pubTime":"2025-09-21 04:14","pubTimestamp":1758399254,"startTime":"0","endTime":"0","summary":"截至2025年9月19日收盘，华恒生物报收于33.83元，较上周的36.95元下跌8.44%。本周，华恒生物9月15日盘中最高价报36.79元。本周关注点公司公告汇总：华恒生物拟发行H股并在香港联交所主板上市，发行规模不超过发行后总股本的15%。公司公告汇总安徽华恒生物科技股份有限公司拟发行H股股票并在香港联合交易所主板上市，旨在推进全球化战略、优化资本结构、提升治理水平。授权董事会全权处理发行上市相关事宜。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092100001044.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","688639"],"gpt_icon":0},{"id":"2568052504","title":"华恒生物（688639）披露核心技术人员离职事项，9月18日股价下跌3.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568052504","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568052504?lang=zh_cn&edition=full","pubTime":"2025-09-18 22:34","pubTimestamp":1758206061,"startTime":"0","endTime":"0","summary":"截至2025年9月18日收盘，华恒生物报收于33.2元，较前一交易日下跌3.18%，最新总市值为83.04亿元。近日，兴业证券股份有限公司发布了关于安徽华恒生物科技股份有限公司核心技术人员离职的核查意见。公告显示，华恒生物核心技术人员刘志成因个人原因与公司协商一致解除劳动关系，不再担任公司任何职务。保荐机构认为本次核心技术人员离职对公司不构成实质性影响，无异议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091800037601.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","688639"],"gpt_icon":0},{"id":"2568632124","title":"华恒生物冲刺“A+H”：上半年净利降超两成，主要产品价格下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2568632124","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568632124?lang=zh_cn&edition=full","pubTime":"2025-09-17 15:09","pubTimestamp":1758092940,"startTime":"0","endTime":"0","summary":"在赴港上市路上，华恒生物仍面临不少挑战。9月15日，新京报贝壳财经记者获悉，安徽华恒生物科技股份有限公司（以下简称“华恒生物”）发布公告，公司召开第四届董事会第二十三次会议，审议 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/20250917/c671202888.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/20250917/c671202888.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["BK0229","688639"],"gpt_icon":0},{"id":"2565250173","title":"合成生物龙头A+H上市加速，利润连降能否获得港股青睐？","url":"https://stock-news.laohu8.com/highlight/detail?id=2565250173","media":"投资时报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565250173?lang=zh_cn&edition=full","pubTime":"2025-09-08 16:32","pubTimestamp":1757320320,"startTime":"0","endTime":"0","summary":"近日，A股合成生物代表企业及氨基酸龙头企业安徽华恒生物科技股份有限公司（下称华恒生物，688639.SH）密集发布多项修订后的公司治理相关制度，为其港股上市做着准备。不久前的7月末，华恒 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/20250908/c670962003.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["BK0229","688639"],"gpt_icon":0},{"id":"2565254870","title":"每周股票复盘：华恒生物（688639）拟发行H股募资用于全球化布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2565254870","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565254870?lang=zh_cn&edition=full","pubTime":"2025-09-07 04:17","pubTimestamp":1757189831,"startTime":"0","endTime":"0","summary":"截至2025年9月5日收盘，华恒生物报收于36.92元，较上周的37.32元下跌1.07%。本周，华恒生物9月3日盘中最高价报39.66元。本周关注点公司公告汇总：华恒生物拟发行H股募资用于全球化布局、技术研发及产能升级。聘任容诚（香港）会计师事务所有限公司为H股发行并上市审计机构，该事项尚需股东大会审议。利润下滑主要由于L-缬氨酸产品价格及毛利率下降，叠加股本增加及期间费用上升所致。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090700000830.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"gpt_icon":0},{"id":"2564377991","title":"华恒生物(688639.SH)拟发行H股股票并在香港联交所主板挂牌上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2564377991","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564377991?lang=zh_cn&edition=full","pubTime":"2025-09-04 21:08","pubTimestamp":1756991293,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华恒生物(688639.SH)发布公告，公司董事会审议通过《关于公司发行H股股票并在香港联合交易所有限公司上市的议案》，为深入推进公司全球化发展战略，提升品牌影响力与核心竞争力，巩固行业领先地位，充分借助国际资本市场的资源与机制优势，优化资本结构，拓宽多元融资渠道，全面提升公司治理水平和综合实力，公司拟发行境外上市外资股(H股)股票并申请在香港联合交易所有限公司(简称“香港联交所”)主板挂牌上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1341691.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"华恒生物(688639.SH)拟发行H股股票并在香港联交所主板挂牌上市","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688639","BK0229"],"gpt_icon":0},{"id":"2564778483","title":"华恒生物：拟发行H股股票并在香港联交所主板挂牌上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2564778483","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564778483?lang=zh_cn&edition=full","pubTime":"2025-09-04 21:00","pubTimestamp":1756990827,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0229","688639"],"gpt_icon":0},{"id":"2564322370","title":"9月4日华恒生物跌6.07%，交银先进制造混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2564322370","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564322370?lang=zh_cn&edition=full","pubTime":"2025-09-04 16:29","pubTimestamp":1756974580,"startTime":"0","endTime":"0","summary":"证券之星消息，9月4日华恒生物跌6.07%，收盘报35.88元，换手率4.15%，成交量10.39万手，成交额3.8亿元。根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共7家，其中持有数量最多的公募基金为交银施罗德基金的交银先进制造混合A。交银先进制造混合A目前规模为43.68亿元，最新净值5.0446，较上一交易日上涨0.25%，近一年上涨67.8%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090400025334.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","399260","688639"],"gpt_icon":0},{"id":"2562401697","title":"华恒生物(688639.SH)：上半年净利润1.15亿元，同比下降23.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562401697","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562401697?lang=zh_cn&edition=full","pubTime":"2025-08-27 22:37","pubTimestamp":1756305477,"startTime":"0","endTime":"0","summary":"格隆汇8月27日丨华恒生物(688639.SH)公布2025年半年度报告，报告期内，公司实现营业收入14.89亿元，同比增加46.54%；归属于上市公司股东的净利润1.15亿元，同比下降23.26%；基本每股收益0.46元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/27223752757250.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["688639"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765922963700,"stockEarnings":[{"period":"1week","weight":0.0052},{"period":"1month","weight":-0.1107},{"period":"3month","weight":0.0076},{"period":"6month","weight":0.1129},{"period":"1year","weight":-0.0188},{"period":"ytd","weight":0.0808}],"compareEarnings":[{"period":"1week","weight":-0.0217},{"period":"1month","weight":-0.0415},{"period":"3month","weight":-0.0133},{"period":"6month","weight":0.1376},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.1411}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"安徽华恒生物科技股份有限公司","boardCode":"AI0026","boardName":"化学原料和化学制品制造业","stockholders":"10213人(较上一季度增加23.84%)","perCapita":"24489股","listingDate":"2021-04-22","address":"安徽省合肥市长丰县双凤工业区","registeredCapital":"25011万元","survey":" 安徽华恒生物科技股份有限公司的主营业务是氨基酸及其衍生物产品研发、生产、销售。公司的主要产品是氨基酸及其衍生物产品。","listedPrice":23.16},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华恒生物(688639)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华恒生物(688639)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华恒生物,688639,华恒生物股票,华恒生物股票老虎,华恒生物股票老虎国际,华恒生物行情,华恒生物股票行情,华恒生物股价,华恒生物股市,华恒生物股票价格,华恒生物股票交易,华恒生物股票购买,华恒生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华恒生物(688639)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华恒生物(688639)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}